Lixte Biotechnology Holdings Stock Market Value
| LIXT Stock | USD 1.52 0.03 2.01% |
| Symbol | Lixte |
Lixte Biotechnology Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lixte Biotechnology. If investors know Lixte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lixte Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.73) | Return On Assets (0.87) | Return On Equity (1.63) |
The market value of Lixte Biotechnology is measured differently than its book value, which is the value of Lixte that is recorded on the company's balance sheet. Investors also form their own opinion of Lixte Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Lixte Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lixte Biotechnology's market value can be influenced by many factors that don't directly affect Lixte Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lixte Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lixte Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lixte Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Lixte Biotechnology 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Lixte Biotechnology's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Lixte Biotechnology.
| 10/23/2024 |
| 11/22/2024 |
If you would invest 0.00 in Lixte Biotechnology on October 23, 2024 and sell it all today you would earn a total of 0.00 from holding Lixte Biotechnology Holdings or generate 0.0% return on investment in Lixte Biotechnology over 30 days. Lixte Biotechnology is related to or competes with Allarity Therapeutics, Neurobo Pharmaceuticals, Virax Biolabs, Quoin Pharmaceuticals, Indaptus Therapeutics, Pasithea Therapeutics, and Biodexa Pharmaceticals. Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzym... More
Lixte Biotechnology Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Lixte Biotechnology's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Lixte Biotechnology Holdings upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 6.15 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 70.38 | |||
| Value At Risk | (11.60) | |||
| Potential Upside | 7.95 |
Lixte Biotechnology Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Lixte Biotechnology's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Lixte Biotechnology's standard deviation. In reality, there are many statistical measures that can use Lixte Biotechnology historical prices to predict the future Lixte Biotechnology's volatility.| Risk Adjusted Performance | 0.0133 | |||
| Jensen Alpha | 0.124 | |||
| Total Risk Alpha | (1.13) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | (0.04) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lixte Biotechnology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Lixte Biotechnology Backtested Returns
Lixte Biotechnology has Sharpe Ratio of -0.0109, which conveys that the firm had a -0.0109% return per unit of risk over the last 3 months. Lixte Biotechnology exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Lixte Biotechnology's Mean Deviation of 4.49, downside deviation of 6.15, and Risk Adjusted Performance of 0.0133 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of -0.86, which conveys possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning Lixte Biotechnology are expected to decrease slowly. On the other hand, during market turmoil, Lixte Biotechnology is expected to outperform it slightly. At this point, Lixte Biotechnology has a negative expected return of -0.0982%. Please make sure to verify Lixte Biotechnology's treynor ratio, expected short fall, as well as the relationship between the Expected Short fall and day median price , to decide if Lixte Biotechnology performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.29 |
Weak reverse predictability
Lixte Biotechnology Holdings has weak reverse predictability. Overlapping area represents the amount of predictability between Lixte Biotechnology time series from 23rd of October 2024 to 7th of November 2024 and 7th of November 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Lixte Biotechnology price movement. The serial correlation of -0.29 indicates that nearly 29.0% of current Lixte Biotechnology price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.29 | |
| Spearman Rank Test | -0.27 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Lixte Biotechnology lagged returns against current returns
Autocorrelation, which is Lixte Biotechnology stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Lixte Biotechnology's stock expected returns. We can calculate the autocorrelation of Lixte Biotechnology returns to help us make a trade decision. For example, suppose you find that Lixte Biotechnology has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Lixte Biotechnology regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Lixte Biotechnology stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Lixte Biotechnology stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Lixte Biotechnology stock over time.
Current vs Lagged Prices |
| Timeline |
Lixte Biotechnology Lagged Returns
When evaluating Lixte Biotechnology's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Lixte Biotechnology stock have on its future price. Lixte Biotechnology autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Lixte Biotechnology autocorrelation shows the relationship between Lixte Biotechnology stock current value and its past values and can show if there is a momentum factor associated with investing in Lixte Biotechnology Holdings.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Lixte Stock Analysis
When running Lixte Biotechnology's price analysis, check to measure Lixte Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lixte Biotechnology is operating at the current time. Most of Lixte Biotechnology's value examination focuses on studying past and present price action to predict the probability of Lixte Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lixte Biotechnology's price. Additionally, you may evaluate how the addition of Lixte Biotechnology to your portfolios can decrease your overall portfolio volatility.